The global market for Peripheral Intravenous (IV) Catheters was valued at US$5.6 Billion in 2024 and is projected to reach US$7.7 Billion by 2030, growing at a CAGR of 5.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The design and material composition of peripheral IV catheters have evolved to enhance patient safety and comfort. Traditionally made from polyurethane or silicone, these catheters are designed to be biocompatible to reduce the risk of venous irritation and minimize the likelihood of allergic reactions. Recent innovations include the development of catheters with antimicrobial and antithrombotic coatings to reduce the incidence of catheter-related bloodstream infections and thrombosis, respectively. Furthermore, the use of safety-engineered devices with retractable needles has become more widespread, significantly reducing the incidence of needlestick injuries among healthcare providers. These catheters come in various gauges and lengths, allowing for customization based on patient needs and the viscosity of the infused substance, thus optimizing the flow rates and reducing the risks of complications.
The growth in the peripheral intravenous catheter market is driven by several factors, including advancements in catheter technology, an increase in the prevalence of chronic diseases, and a rising emphasis on healthcare quality and patient safety. The aging population globally has led to a higher incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases, all of which often require IV therapeutic treatment modalities. Additionally, the growing trend towards minimally invasive treatments has fueled the demand for devices that can be efficiently managed in outpatient settings, including home healthcare. The market is also benefiting from the increasing investment in healthcare infrastructure and services, particularly in emerging economies where access to basic medical care is expanding. Furthermore, ongoing research and development activities aimed at further minimizing infection rates and improving patient comfort are poised to propel the adoption of newer, more advanced peripheral IV catheter products. This market dynamic is supported by a competitive landscape where manufacturers are continually innovating to meet the stringent safety standards required by regulatory authorities worldwide, ensuring sustained growth in this sector.
Global Peripheral Intravenous (IV) Catheters Market - Key Trends and Drivers Summarized
Peripheral Intravenous (IV) Catheters are essential medical devices used extensively in healthcare settings for the administration of medications, fluids, electrolytes, and nutritional compounds directly into a patient's venous system. Their primary function is to provide immediate access to the bloodstream, facilitating rapid absorption and effect of administered substances. These catheters are most commonly placed in peripheral veins such as those in the arms or hands, but alternative sites can include the scalp veins in infants or the feet in adults when other sites are not viable. The catheter itself consists of a flexible tube that is inserted into a vein using a needle, which is subsequently removed, leaving only the tube in place. This setup minimizes the patient's discomfort and maintains an open channel to the bloodstream for the required duration of treatment, which can range from a few hours to several weeks, depending on the clinical situation.The design and material composition of peripheral IV catheters have evolved to enhance patient safety and comfort. Traditionally made from polyurethane or silicone, these catheters are designed to be biocompatible to reduce the risk of venous irritation and minimize the likelihood of allergic reactions. Recent innovations include the development of catheters with antimicrobial and antithrombotic coatings to reduce the incidence of catheter-related bloodstream infections and thrombosis, respectively. Furthermore, the use of safety-engineered devices with retractable needles has become more widespread, significantly reducing the incidence of needlestick injuries among healthcare providers. These catheters come in various gauges and lengths, allowing for customization based on patient needs and the viscosity of the infused substance, thus optimizing the flow rates and reducing the risks of complications.
The growth in the peripheral intravenous catheter market is driven by several factors, including advancements in catheter technology, an increase in the prevalence of chronic diseases, and a rising emphasis on healthcare quality and patient safety. The aging population globally has led to a higher incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases, all of which often require IV therapeutic treatment modalities. Additionally, the growing trend towards minimally invasive treatments has fueled the demand for devices that can be efficiently managed in outpatient settings, including home healthcare. The market is also benefiting from the increasing investment in healthcare infrastructure and services, particularly in emerging economies where access to basic medical care is expanding. Furthermore, ongoing research and development activities aimed at further minimizing infection rates and improving patient comfort are poised to propel the adoption of newer, more advanced peripheral IV catheter products. This market dynamic is supported by a competitive landscape where manufacturers are continually innovating to meet the stringent safety standards required by regulatory authorities worldwide, ensuring sustained growth in this sector.
Report Scope
The report analyzes the Peripheral Intravenous (IV) Catheters market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments
Product (Short Catheters, Integrated / Closed Catheters); Technology (Safety Peripheral Intravenous Catheters, Conventional Peripheral Intravenous Catheters); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses).Geographic Regions/Countries
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.Key Insights:
- Market Growth: Understand the significant growth trajectory of the Short Catheters segment, which is expected to reach US$4.6 Billion by 2030 with a CAGR of a 4.9%. The Integrated / Closed Catheters segment is also set to grow at 6.6% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $1.5 Billion in 2024, and China, forecasted to grow at an impressive 8.9% CAGR to reach $1.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Argon Medical Devices, Inc., B. Braun Medical Inc., Becton, Dickinson and Company, ICU Medical, Inc., MEDEREN Neotech Ltd and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Peripheral Intravenous (IV) Catheters Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Peripheral Intravenous (IV) Catheters Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Peripheral Intravenous (IV) Catheters Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 45 major companies featured in this Peripheral Intravenous (IV) Catheters market report include:
- Argon Medical Devices, Inc.
- B. Braun Medical Inc.
- Becton, Dickinson and Company
- ICU Medical, Inc.
- MEDEREN Neotech Ltd
- Nipro Medical Corporation
- Delta Med S.p.A
- Vogt Medical GMBH
- Teleflex, Inc.
- Terumo Medical Corporation
- Vygon SAS
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Argon Medical Devices, Inc.
- B. Braun Medical Inc.
- Becton, Dickinson and Company
- ICU Medical, Inc.
- MEDEREN Neotech Ltd
- Nipro Medical Corporation
- Delta Med S.p.A
- Vogt Medical GMBH
- Teleflex, Inc.
- Terumo Medical Corporation
- Vygon SAS
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 372 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 5.6 Billion |
| Forecasted Market Value ( USD | $ 7.7 Billion |
| Compound Annual Growth Rate | 5.5% |
| Regions Covered | Global |
